Prospective randomized trial on Pemafibrate versus omega-3-acid ethyl in patients with untreated hypertriglyceridemia
Not Applicable
- Conditions
- Hypertriglyceridemia
- Registration Number
- JPRN-UMIN000037026
- Lead Sponsor
- Sekino Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
sCr>1.5mg/dL(treating with statin) sCr>2.5mg/dL(untreating with statin) Patients who were deemed not appropriate to participate in this study by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TG
- Secondary Outcome Measures
Name Time Method DL,HDL,T-cho,sCr,eGFR Remnant-Like Particle,Apo A-I,B,E,fatty acid fractionation,urinary albumin,cystitis C,oxidized LDL Cartotid echo,ABI,FMD